S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

GLMD Galmed Pharmaceuticals Ltd

2.55

-0.15 (-5.56%)

After Hours

Last Updated: 08:02:00

Delayed by 15 minutes

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Galmed Pharmaceuticals (NASDAQ:GLMD)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Galmed Pharmaceuticals Charts.

Galmed Pharmaceuticals (NASDAQ:GLMD)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Galmed Pharmaceuticals Charts.

Galmed Pharmaceuticals Ltd News

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Wednesday 19 February 2025 (2 days ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Wednesday 8 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Friday 15 November 2024 (3 months ago) • Edgar (US Regulatory)

Form F-3 - Registration statement by foreign private issuers
Friday 15 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Friday 15 November 2024 (3 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 15 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Tuesday 29 October 2024 (4 months ago) • Edgar (US Regulatory)

Form F-1 - Registration statement for certain foreign private issuers
Tuesday 22 October 2024 (4 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 22 October 2024 (4 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 16 October 2024 (4 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 25 September 2024 (5 months ago) • Edgar (US Regulatory)

Galmed publishes Results from Aramchol Phase 3 Open Label part in Hepatology
Wednesday 25 September 2024 (5 months ago) • PR Newswire (US)

More Galmed Pharmaceuticals Ltd News Articles

Australian SE All Ordina...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions